Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fenlai Tan, M.D./Ph.D.
Zhejiang Betapharma Inc.
Study Director - Li Zhang, M.D.
Sun Yat-Sen University Cancer Center
Principal Investigator - Yan Sun, M.D.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 307 Hospital of Pla
Beijing, Beijing Municipality, China
- Beijing Chao-Yang Hospital
Beijing, Beijing Municipality, China
- Beijing Chest Hospital
Beijing, Beijing Municipality, China
- Bejing Cancer Hospital
Beijing, Beijing Municipality, China
- Cancer Hospital, Chinese Academy of Medical Science
Beijing, Beijing Municipality, China
- Chinese Pla General Hospital
Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
- Peking University Third Hospital
Beijing, Beijing Municipality, China
- Third Affiliated Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, China
- Guangdong General Hospital
Guangzhou, Guangdong, China
- Guanghzou General Hospital of Pla
Guangzhou, Guangdong, China
- Nanfang Hospital， Southern Medical University
Guangzhou, Guangdong, China
- Sun Yat-Sen Univerisity Cancer Center
Guanzhou, Guangdong, China
- Hunan Cancer Hospital
Changsha, Hunan, China
- the Second Xiangya Hospital，central South University
Changsha, Hunan, China
- 81 Hospital of Pla
Nanjing, Jiangsu, China
- Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
- Nanjing General Hospital of Nanjing Command，pla
Nanjing, Jiangsu, China
- Jilin Cancer Hospital
Changchun, Jilin, China
- Changhai Hospital， Second Military Medical University
Shanghai, Shanghai Municipality, China
- Ruijin Hospital，shanghai Jiao-Tong University
Shanghai, Shanghai Municipality, China
- Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
- Zhongshan Hospital，fudan University
Shanghai, Shanghai Municipality, China
- Tangdu Hospital, Fourth Military Medical University
Xi’an, Shanxi, China
- Xijing Hospital, Fourth Military Medical University
Xi’an, Shanxi, China
- the First Affiliated Hospital of College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
- Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- 31 Mar 2010
- Completion
- 31 Dec 2011
- Last update posted
- 14 Feb 2014
- Registered enrollment
- 399
- Registry id
- NCT01040780
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.